WTR Small-Cap Spotlight

Send us Fan Mail BLGO’s CEO Dennis Calvert joins Dmitry Silversteyn and Tim Gerdeman to discuss the company’s science-driven approach to developing and commercializing innovative solutions to address critical environmental problems such as “forever chemicals”, air and water quality and cost-effective power storage.

Send us Fan Mail Join WTR’s Tim Regan, Curtis Shauger, Dr. John Roy and as they chat about Crypto, AI, and the recent WTR AI and Technology Investor Conference.

Send us Fan Mail In this special episode, Nicole is joined by industry experts Tim Regan and Tim Gerdeman from Water Tower Research. Together, they embark on a dynamic conversation delving into the latest trends, challenges, and opportunities in women's health. They discuss continued progress on the markets adoption of the Company’s OvaSuite products and other areas of growth for AWH. 

Send us Fan Mail TMC’s CFO Craig Shesky and the company’s Head of Stakeholder Engagement Corey McLachlan join WTR’s Dmitry Silversteyn and Tim Gerdeman to discuss the importance of deep-sea mining as a source of critical metals for global energy transition with the least possible negative impact on the planet and the people, and look at the current state of the industry, political tailwinds, and c...

Send us Fan Mail Join WTR’s Tim Regan and Dr. John Roy and as they chat about Crypto and AI, and the hype surrounding it, and which Crypto and AI companies are presenting at the WTR AI and Technology Investor Conference on April 10 and 11th. 

Send us Fan Mail Canada-based PharmAla Biotech's Founding CEO and President Nick Kadysh joins WTR's Tim Regan and Robert Sassoon to discuss PharmAla's  focus on MDMA, the regulatory environment, and the company's recipe for success in the psychedelics space. Founded three years ago,  the company reported annualized revenue of C$3 million and achieved a first-time profit for its...

Send us Fan Mail Doug talks about factors impacting the very soft start to 2024 for the publicly traded direct selling stocks, with forward earnings being sharply reduced coming out of the 2023 4Q earnings cycle and forward multiples remaining at generational lows.  However, Doug notes that these companies have been around for a while and have seen tough stretches before, and successfully managed...

Send us Fan Mail Tim Regan is joined by Peter Gastreich and Chris Degner to discuss the changing landscape for the oil & gas industry in Latin America and Colombia. Among the key themes discussed include strategies of onshore independent operators and natural gas in the context of energy transition.

Send us Fan Mail WTR’s Tim Regan and Jesse Redmond were joined by Benzinga’s Elliot Lane to recap the company’s recent Cannabis Spotlight event in Los Angeles. This was Benzinga’s first regional event, and the group discussed the sentiment among operators, favorite moments, and biggest takeaways. The episode concludes by looking forward to Benzinga’s Cannabis Capital Conference in Hollywood, Flori...

Send us Fan Mail BayMedica is the commercial business arm of rare cannabinoids-based drug developer InMed Pharmaceuticals (NASDAQ: INM). BayMedica produces and sells synthesized high purity and consistent rare cannabinoid ingredients to the Health & Wellness sector. BayMedica’s business has quickly grown its annual revenues to more than $5 million over the last 12 months.  

Send us Fan Mail Grown Rogue CEO Obie Strickler joined WTR’s Jesse Redmond to discuss how it grows low-cost craft cannabis at scale. The company has found success in historically different markets like Oregon and Michigan and Strickler shared the steps it has taken to compete in these open-license states. Grown Rogue is expanding, and he explained why it chose New Jersey and how it is partnering w...

Send us Fan Mail LifeVantage CEO Steve Fife and CFO Carl Aure join WTR’s Tim Regan and Doug Lane to talk about the company’s recent Global Kickoff event, featuring the introduction of this year’s “Rise ERA” theme to its Consultant base worldwide.  Also covered is the announcement of Phase 2 of its LV360 initiatives this year, as well as a recap of Phase 1 introduced a year ago.  Additionally, new...

Send us Fan Mail Tim Regan is joined by Dmitry Silversteyn to recap what has happened in the chemicals and materials technology industries in 2023 and to provide an outlook for the industry in 2024.

Send us Fan Mail Join WTR’s Jesse Redmond and John Roy and as they chat with Bakkt’s Head of Institutional Solutions, Ray Kamrath, about how Bakkt’s custody capabilities are key for its institutional clients, and how the recent approval by the SEC of several Bitcoin ETFs is changing the US market.

Send us Fan Mail Tim Regan is joined by Budd Bugatch and Rex Henderson, who recap the 2024 WTR Furniture/Furnishings Virtual Conference and provide their takeaways from the event and their insights and outlook for the Consumer Hardlines sector.

Send us Fan Mail Join Tim Regan, Lynne Collier, and Doug Lane as they discuss their takeaways from the recent ICR Conference.

Send us Fan Mail Join Tim Regan and Jesse Redmond as Jesse discusses the tumultuous year for cannabis and what to look for going into 2024. Then Tim talks to Robert Sassoon to gauge the outlook on psychedelics and the progress being made with psychiatric treatments.

Send us Fan Mail Join Curtis Shauger and Tim Regan as well as John Roy and Jesse Redmond as Curtis and John discuss the top tech trends to look out for in 2024. Part 2 of 3 of our WTR Recap Episodes.

Send us Fan Mail Join Jesse Redmond, Budd Bugatch, and Rex Henderson for a recap of the furniture sector going into the new year, as well as Tim Regan and Doug Lane for a discussion on consumer product trends to look out for in 2024. Part 1 of 3 of our WTR Recap Episodes.

Send us Fan Mail Standard Lithium’s CEO, Robert Mintak, joins WTR’s Jesse Redmond and Jeff Robertson to discuss the company’s plans to become a major domestic producer of battery-quality lithium. The company’s projects in Southern Arkansas and exploration acreage in East Texas will extract lithium from brine produced from the Smackover formation. Smackover brines have the highest known lithium con...

Send us Fan Mail Soluna Holding’s CEO John Belizaire joins WTR’s Tim Regan and Graham Mattison to talk about Soluna’s impressive business turnaround in 2023, including the projects that are online today and their growing adjusted EBITDA contributions. Belizaire also talks about new projects under development, incremental revenue sources, and the company’s recently announced AI pilot at Project Dor...

Send us Fan Mail  This episode discusses our upcoming Climate Investor Conference in NYC on December 7. We are looking at the challenges and opportunities facing sustainable investing and the key companies and technologies likely to thrive in the year ahead. With the broader pullback in the sector, investors can reset the bar and look for the best and brightest companies leveraging the best tailwi...

Send us Fan Mail Water’s Tower’s Head of Business Development Tim Regan was joined by WTR’s Managing Director of Technology Dr. John Roy, and Creative Realities (CREX) CEO Rick Mills to talk about the digital signage space.  Mills discusses Creative’s customers (Best Buy, Verizon, Dallas Cowboys, Macy’s, 7-11, and Panera), his shift to more SaaS, and the company’s confidence in its 50% growth reve...

Send us Fan Mail Water’s Tower’s Head of Business Development Tim Regan was joined by WTR’s Head of Consumer Discretionary Lynne Collier to talk about the state of the restaurant Industry.  Collier began by highlighting her takeaways from the recent Restaurant Development and Finance Conference.  She then discussed the role that technology is playing in the restaurant industry, menu pricing expect...

Send us Fan Mail Water Tower Research Head of Healthcare Services and Medical Devices Matt Borsch was joined by John Bencich, CEO of Achieve Life Sciences (ACHV). Bencich provided an overview of the company and its key product cytisinicline, which through multiple clinical trials, has shown strong efficacy and safety in treating nicotine addiction. Bencich pointed to significant progress achieved...